Abiopharma

Morningstar, Inc. to Announce Second-Quarter 2026 Financial Results on July 29

Hyperliquid Strategies Inc Added to the Russell 3000, Russell 2000 and S&P Global BMI Indices

Universal Display Corporation’s Dr. Julie Brown Receives Prestigious IEEE Frederik Philips Award

Pathfinder Bancorp, Inc. Declares Dividend

BRAEMAR HOTELS & RESORTS EXTENDS RITZ-CARLTON LAKE TAHOE MORTGAGE LOAN

DHT Holdings, Inc. Announces Fleet Upgrades and Charter Management

Norwegian Cruise Line Names Lee Applbaum as Chief Marketing Officer

Cogent Communications Announces Closing of Sale of 10 Data Center Facilities

Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival

BNY Mellon Municipal Bond Closed-End Funds Declare Distributions